Chronic kidney disease clinics in India are crowded with patients with diabetes and hypertension, many presenting late, which makes cross-sectional and cohort studies quick to recruit. The sample titles explore non-albuminuric diabetic kidney disease, link retinopathy and uric acid to albuminuria, measure anaemia and iron deficiency across eGFR stages, and examine vitamin D, mineral bone disorder and carotid intima-media thickness.

A cross-sectional design is efficient but cannot show progression, so consider a short prospective cohort if you want outcomes. Staging needs repeated eGFR values over time to confirm chronicity. Parathyroid hormone, vitamin D and phosphate assays add cost, and patients may already take supplements that alter results. Multidisciplinary care studies need agreement from dietetics and other departments.

1CKD & CKD-MBD: catalogue at a glance

Our catalogue (shared with medicalthesistopic.in) has 65 DM Nephrology titles in CKD & CKD-MBD. Study designs used most often in this area:

Study designTitles
Hospital-based cross-sectional study18
Prospective observational study15
Retrospective record-based study8
Prospective analytical study8
Randomized controlled trial5
Prospective interventional study4

This page is part of DM Nephrology thesis topics.

250 CKD & CKD-MBD thesis titles

Free to read, newest first. Each has two optional paid add-ons on medicalthesistopic.in: objectives (₹50) and a full plan / synopsis (₹500) for that exact title, paid separately there.

  1. 001

    Masked and white-coat hypertension on ambulatory blood pressure monitoring in non-dialysis chronic kidney disease

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  2. 002

    Symptom burden and quality of life in elderly patients with CKD stage 5 on conservative kidney management

    CKD & CKD-MBDProspective observational studyClinical Spectrum / Profile
  3. 003

    Ketoanalogue-supplemented very low-protein diet versus standard low-protein diet in CKD stage 4: eGFR decline and nutritional status

    CKD & CKD-MBDRandomized controlled trialComparative / Interventional
  4. 004

    Bone mineral density by DXA and its association with serum parathyroid hormone and alkaline phosphatase in CKD stages 3 to 5

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  5. 005

    Sevelamer versus calcium acetate in non-dialysis CKD stages 4 and 5 with hyperphosphataemia: phosphate and FGF-23 control

    CKD & CKD-MBDProspective comparative studyComparative / Interventional
  6. 006

    Febuxostat versus no urate-lowering therapy in asymptomatic hyperuricaemia with CKD stages 3 and 4: eGFR decline at 12 months

    CKD & CKD-MBDRandomized controlled trialComparative / Interventional
  7. 007

    Magnitude of initial eGFR dip after SGLT2 inhibitor initiation and its association with 12-month kidney outcome in chronic kidney disease

    CKD & CKD-MBDProspective observational studyOutcome / Prognostic
  8. 008

    Prevalence and stage of chronic kidney disease among patients with type 2 diabetes attending a diabetes clinic

    CKD & CKD-MBDHospital-based cross-sectional studyClinical Spectrum / Profile
  9. 009

    Oral sodium bicarbonate and progression of chronic kidney disease with metabolic acidosis

    CKD & CKD-MBDRandomized controlled trialComparative / Interventional
  10. 010

    Depression on PHQ-9 in chronic kidney disease and dialysis patients and its association with quality of life

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  11. 011

    Cognitive impairment on the Montreal Cognitive Assessment in chronic kidney disease

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  12. 012

    Prevalence of frailty in non-dialysis chronic kidney disease and its association with eGFR

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  13. 013

    Protein-energy wasting and sarcopenia in CKD stages 3 to 5 and their association with mortality

    CKD & CKD-MBDProspective observational studyAssociation / Correlation
  14. 014

    Roxadustat versus erythropoietin for anaemia of chronic kidney disease: haemoglobin response at 24 weeks

    CKD & CKD-MBDProspective comparative studyComparative / Interventional
  15. 015

    Oral ferrous sulphate versus intravenous ferric carboxymaltose for anaemia in non-dialysis chronic kidney disease

    CKD & CKD-MBDRandomized controlled trialComparative / Interventional
  16. 016

    Prevalence of vascular calcification on lateral abdominal radiograph in non-dialysis chronic kidney disease

    CKD & CKD-MBDHospital-based cross-sectional studyClinical Spectrum / Profile
  17. 017

    Serum FGF-23 and its association with left ventricular hypertrophy in CKD stages 3 to 5

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  18. 018

    Finerenone added to RAAS blockade in diabetic kidney disease: albuminuria reduction at six months

    CKD & CKD-MBDProspective interventional studyComparative / Interventional
  19. 019

    Effect of SGLT2 inhibitors on eGFR decline and proteinuria in non-diabetic chronic kidney disease

    CKD & CKD-MBDProspective observational studyOutcome / Prognostic
  20. 020

    Clinico-epidemiological profile of chronic kidney disease of unknown aetiology in agricultural communities

    CKD & CKD-MBDCommunity-based cross-sectional studyClinical Spectrum / Profile
  21. 021

    Prevalence of iron deficiency and its correlation with haemoglobin in non-dialysis chronic kidney disease

    CKD & CKD-MBDRetrospective record-based studyAssociation / Correlation
  22. 022

    Correlation of urine albumin-creatinine ratio with severity and outcome in chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  23. 023

    Ultrasonographic kidney size and cortical echogenicity in relation to eGFR and severity of chronic kidney disease

    CKD & CKD-MBDHospital-based cross-sectional studyDiagnostic / Tool Evaluation
  24. 024

    Demographic and clinical spectrum of chronic kidney disease with emphasis on anemia control

    CKD & CKD-MBDProspective analytical studyClinical Spectrum / Profile
  25. 025

    Effectiveness of patient education intervention on quality of life among patients with diabetic kidney disease at a tertiary care hospital

    CKD & CKD-MBDProspective interventional studyComparative / Interventional
  26. 026

    Effect of SGLT2 inhibitor therapy on albuminuria and eGFR in patients with diabetic kidney disease

    CKD & CKD-MBDProspective interventional studyComparative / Interventional
  27. 027

    Prevalence of anaemia and its association with eGFR and albuminuria in diabetic kidney disease

    CKD & CKD-MBDProspective analytical studyOutcome / Prognostic
  28. 028

    Prevalence of frailty and its association with hospitalisation in elderly patients with chronic kidney disease

    CKD & CKD-MBDProspective observational studyClinical Spectrum / Profile
  29. 029

    Prevalence of CKD-mineral bone disorder and its association with vascular calcification in diabetic kidney disease

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  30. 030

    Clinical profile, severity grading and outcome spectrum of chronic kidney disease

    CKD & CKD-MBDProspective observational studyClinical Spectrum / Profile
  31. 031

    Predictors of progression to end-stage kidney disease in elderly patients with chronic kidney disease stages 3-5

    CKD & CKD-MBDRetrospective record-based studyOutcome / Prognostic
  32. 032

    Renal resistive index as a marker of disease severity and its correlation with albuminuria in diabetic kidney disease

    CKD & CKD-MBDProspective analytical studyDiagnostic / Tool Evaluation
  33. 033

    Clinical profile and comorbidity burden of diabetic kidney disease in elderly patients at a tertiary care hospital

    CKD & CKD-MBDProspective analytical studyClinical Spectrum / Profile
  34. 034

    Assessment of fluid overload by bioimpedance analysis and its association with blood pressure and stage in non-dialysis chronic kidney disease

    CKD & CKD-MBDProspective analytical studyDiagnostic / Tool Evaluation
  35. 035

    Clinical profile, severity grading and outcome spectrum of diabetic kidney disease

    CKD & CKD-MBDHospital-based cross-sectional studyClinical Spectrum / Profile
  36. 036

    Role of renal Doppler in severity assessment and outcome prediction in chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBDProspective observational studyDiagnostic / Tool Evaluation
  37. 037

    Factors associated with prolonged hospital stay in chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBDHospital-based cross-sectional studyOutcome / Prognostic
  38. 038

    Prognostic value of KDIGO GFR-albuminuria risk categories for progression of diabetic kidney disease

    CKD & CKD-MBDProspective analytical studyDiagnostic / Tool Evaluation
  39. 039

    Rate of eGFR decline and its predictors in elderly patients with diabetic kidney disease

    CKD & CKD-MBDHospital-based cross-sectional studyOutcome / Prognostic
  40. 040

    Serum intact parathyroid hormone levels and their association with mineral bone disorder in non-dialysis chronic kidney disease stages 3-5

    CKD & CKD-MBDHospital-based cross-sectional studyAssociation / Correlation
  41. 041

    Prevalence and risk factors of peripheral arterial disease in patients with diabetic kidney disease

    CKD & CKD-MBDProspective observational studyOutcome / Prognostic
  42. 042

    Association of glycated haemoglobin with albuminuria and eGFR decline in diabetic kidney disease

    CKD & CKD-MBDProspective observational studyAssociation / Correlation
  43. 043

    Serum phosphorus control and its association with vascular calcification in patients on maintenance haemodialysis

    CKD & CKD-MBDRetrospective record-based studyAssociation / Correlation
  44. 044

    Prescription pattern and adherence to KDIGO recommendations in management of non-dialysis chronic kidney disease

    CKD & CKD-MBDRetrospective record-based studyOutcome / Prognostic
  45. 045

    Prevalence and risk factors of diabetic kidney disease among patients with type 2 diabetes

    CKD & CKD-MBDProspective observational studyOutcome / Prognostic
  46. 046

    Comparative evaluation of multidisciplinary care approach and standard care in management of chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBDRandomized controlled trialComparative / Interventional
  47. 047

    Cardiovascular risk factors and carotid intima-media thickness in non-dialysis chronic kidney disease

    CKD & CKD-MBDRetrospective record-based studyOutcome / Prognostic
  48. 048

    Relationship between serum uric acid and albuminuria in patients with diabetic kidney disease

    CKD & CKD-MBDProspective observational studyAssociation / Correlation
  49. 049

    Burden of complications and mortality predictors in diabetic kidney disease at a tertiary care hospital

    CKD & CKD-MBDProspective observational studyOutcome / Prognostic
  50. 050

    Prevalence of anaemia and iron deficiency in non-dialysis chronic kidney disease and its correlation with eGFR

    CKD & CKD-MBDQuasi-experimental studyComparative / Interventional

3Download DM Nephrology titles in Excel

₹1 per title: the latest 100 DM Nephrology titles for ₹100, the latest 500 for ₹500, or search a keyword and pay only for the titles found. The Excel downloads right after payment.

📥 DM Nephrology Titles in Excel · ₹1 per title

100 titles = ₹100. Secure checkout (UPI / QR / card) on our sister site medicalthesistopic.in; the Excel downloads instantly.

1 · Speciality package (newest first)

2 · Or search a keyword

Or browse free titles by speciality →

4Tips for a CKD & CKD-MBD thesis

  • Stage patients by KDIGO GFR and albuminuria categories using a stated eGFR equation, and confirm chronicity rather than relying on a single creatinine value.
  • For CKD-MBD, measure calcium, phosphate, intact PTH, alkaline phosphatase and vitamin D together, and record phosphate binders and vitamin D analogues in use.
  • Assess iron status with serum ferritin and transferrin saturation before labelling anaemia as renal, and record erythropoietin and iron therapy for each patient.

Other DM Nephrology subject areas: Kidney Transplantation · Glomerular Diseases · Haemodialysis & Vascular Access · Acute Kidney Injury

Before you finalise a title, read how to choose a thesis topic and how to write aims and objectives.

5Need help with your thesis?

PubMedico helps residents with synopsis, sample size, statistics and the final draft. WhatsApp +91 78787 33004 for a free thesis guidance.

❓ Frequently Asked Questions

Quick answers to common questions on this topic

How many CKD & CKD-MBD thesis titles does the catalogue have?+

It currently has 65 DM Nephrology titles in CKD & CKD-MBD; this page lists 50 of them. The most common designs are hospital-based cross-sectional study, prospective observational study.

Can I get objectives or a synopsis for a CKD & CKD-MBD title?+

Yes. Under each title there are buttons for objectives (₹50) and a full plan or synopsis (₹500). They open the title on medicalthesistopic.in, where you pay separately and get the draft on screen to edit with your guide.